An American Journal of Managed Care® Symposium: Examining Treatment Advancements in Psoriasis and Psoriatic Arthritis

Patients with low psoriasis body surface area (BSA) can have similar quality of life impacts and symptom burdens as those with higher BSA, a new study finds.

August is National Psoriasis Awareness Month, and on this episode of Managed Care Cast, we bring you an excerpt of an interview with a New Jersey dermatologist about the changing concept of psoriasis as more than just a skin disease.

Ustekinumab offers superior itch relief for severe psoriasis compared with guselkumab, new data show.

Once-daily roflumilast provides skin clearance and rapid itch relief with no limitation on duration of use.

The impact of psoriasis on quality of life goes beyond clinical measures, such as psoriasis area severity index (PASI) and body surface area (BSA), a study finds.

Substantial savings opportunities exist by using lower-cost biologics for patients with plaque psoriasis, according to one study.